These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 2563571)
1. The possible role of new beta-adrenoceptor agonists in the treatment of obesity. Meinders AE Neth J Med; 1989 Feb; 34(1-2):1-2. PubMed ID: 2563571 [No Abstract] [Full Text] [Related]
2. Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. van Baak MA; Hul GB; Toubro S; Astrup A; Gottesdiener KM; DeSmet M; Saris WH Clin Pharmacol Ther; 2002 Apr; 71(4):272-9. PubMed ID: 11956510 [TBL] [Abstract][Full Text] [Related]
3. Hyperplasia of brown adipose tissue after chronic stimulation of beta 3-adrenergic receptor in rats. Nagase I; Sasaki N; Tsukazaki K; Yoshida T; Morimatsu M; Saito M Jpn J Vet Res; 1994 Dec; 42(3-4):137-45. PubMed ID: 7745877 [TBL] [Abstract][Full Text] [Related]
5. New approaches to the control of obesity in animals and their clinical potential. Stock MJ Bibl Nutr Dieta; 1989; (44):32-7. PubMed ID: 2571330 [No Abstract] [Full Text] [Related]
6. [Drugs and obesity: current status, prospects for the future]. Apfelbaum M Rev Prat; 1984 Dec; 34(55):3121-4. PubMed ID: 6505592 [No Abstract] [Full Text] [Related]
7. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure]. Astrup A Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391 [TBL] [Abstract][Full Text] [Related]
8. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. Jocken JW; Blaak EE; Schiffelers S; Arner P; van Baak MA; Saris WH Int J Obes (Lond); 2007 May; 31(5):813-9. PubMed ID: 17130852 [TBL] [Abstract][Full Text] [Related]
10. Effect of the adrenergic beta 3-agonist, BRL37344, on heat production by brown adipocytes in obese and in older rats. Yamakawa A; Tanaka E; Nakano S Tokai J Exp Clin Med; 1994 Dec; 19(3-6):139-42. PubMed ID: 7570685 [TBL] [Abstract][Full Text] [Related]
12. Drug strategies for the treatment of obesity. Alemany M; Remesar X; Fernández-López JA IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679 [TBL] [Abstract][Full Text] [Related]
13. [Obesity: current biochemical and therapeutic aspects]. Ducobu J; Hainaut J; Liénart F; Dupont P Rev Med Brux; 1987 Feb; 8(2):67-76. PubMed ID: 3563185 [No Abstract] [Full Text] [Related]
14. [Beta-3 adrenergic receptor--structure and role in obesity and metabolic disorders]. Wiejak J; Wyroba E Postepy Hig Med Dosw; 1999; 53(5):705-15. PubMed ID: 10645145 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of obesity: therapeutic strategies. Kordik CP; Reitz AB J Med Chem; 1999 Jan; 42(2):181-201. PubMed ID: 9925722 [No Abstract] [Full Text] [Related]